✦ LIBER ✦

A pravastatin dose-escalation study in systemic lupus erythematosus

✍ Scribed by Karen H. Costenbader; Matthew H. Liang; Lori B. Chibnik; Juliet Aizer; Hannah Kwon; Victoria Gall; Elizabeth W. Karlson

Publisher: Springer
Year: 2007
Tongue: English
Weight: 321 KB
Volume: 27
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-007-0341-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter study of outcome in system

A multicenter study of outcome in systemic lupus erythematosus.

✍ Dr. Ellen M. Ginzler; Dr. Herbert S. Diamond; Max Weiner; Michael Schlesinger; J 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 985 KB

Mortality in systemic lupus erythematosu

Mortality in systemic lupus erythematosus

✍ S. Bernatsky; J.-F. Boivin; L. Joseph; S. Manzi; E. Ginzler; D. D. Gladman; M. U 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

B cell depletion as a novel treatment fo

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab

✍ R. John Looney; Jennifer H. Anolik; Debbie Campbell; Raymond E. Felgar; Faith Yo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## Objective Safer and more effective therapies are needed for the treatment of systemic lupus erythematosus (SLE). B lymphocytes have been shown to play fundamental pathogenic roles in SLE, and therefore, elimination of B cells with the use of rituximab may represent a new therapy for

Antinucleosome in systemic lupus erythem

Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population

✍ G. A. Sardeto; L. M. Simas; T. S. Skare; R. M. Nisihara; S. R. R. Utiyama 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 128 KB

High-dose cyclophosphamide without stem

High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus

✍ Michelle Petri; Richard J. Jones; Robert A. Brodsky 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Objective: High-dose chemotherapy followed by hematopoietic stem cell transplantation is increasingly being studied as a treatment for severe autoimmune disorders, such as systemic lupus erythematosus (sle). high-dose cyclophosphamide, the foundation of virtually all conditioning regimens for st

A multicenter study of outcome in system

A multicenter study of outcome in systemic lupus erythematosus. ii.

✍ Steven Rosner; Dr. Ellen M. Ginzler; Herbert S. Diamond; Max Weiner; Michael Sch 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

Causes of death were examined for 1,103 systemic lupus erythematosus patients who were followed from 1965 to 1978 at 9 centers that participated in the Lupus Survival Study Group. A total of 222 patients (20%) died. Lupus-related organ system involvement (mainly active nephritis) and infection were